Oral semaglutide (Wegovy; Novo Nordisk) expands GLP-1 weight-loss options, but pharmacy budgets and health care cost pressures persist. The glucagon-like peptide-1 (GLP-1) class has transformed ...

Share on Pinterest A new oral GLP-1 drug effectively lowers blood sugar, boosts weight loss in type 2 diabetes, according to recent trial data. Image credit: Yana Iskayeva/Getty Images About 12% of ...

SAN DIEGO, April 28, 2026 /PRNewswire/ -- FuturHealth, a clinically-guided health platform designed to support long-term health beyond weight loss, today announced that it is expanding its suite of ...

Oral GLP-1 receptor agonists are generating a great deal of excitement as a potential inflection point in diabetes and obesity care. Amid the enthusiasm, however, a quieter and clinically important ...

A Structure Therapeutics obesity pill helped patients lose an average of nearly 40 pounds in a mid-stage clinical trial, keeping the drug competitive in the growing crowd of oral medications pursuing ...

Significant weight loss can trigger hair loss. Learn whether a diet change or supplements can help and how to protect your ...

For the past two years, GLP-1 medications have been a fixture of consumer trend analysis, discussed by everyone from CNBC to sell-side strategists to management consultants. Real apparel expenditure ...

Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for understanding ...

It might surprise you that soft drinks aren’t totally off the menu.

GLP-1 prescriptions for US children with obesity aged 8-11 have risen sharply, signalling a trend that could reshape food choices and family purchasing habits ...

Thu, June 11, 2026 at 5:07 AM UTC Until recently, these medications like Ozempic and Zepbound, were administered only by self-injection. However, for the about 30% of adults who have trypanophobia — ...